Defecetive Drugs: adrugrecall.com
NEWSLETTER
- Accutane
- Advair
- Avandia
- Bextra
- Botox
- Byetta®
- CellCept
- Chantix
- Cipro
- Crestor
- Digitek
- Duragesic Patch
- Fleet Phospho Soda
- Floxin
- Fluoroquinolone
- Fosamax
- Gardasil
- Heparin
- Hydroxycut
- Levaquin
- MRI Dye
- Neurontin
- Noroxin
- Nuvaring
- Ortho Evra
- Paxil
- Permax
- PTU
- Raptiva
- Reglan
- Risperdal
- Serevent
- Seroquel
- Trasylol
- Viagra
- Vioxx
- Yasmin
- Zelnorm
- Zicam
- Zyprexa
Contact Us Today
Use this form to request a free consultation with a qualified attorney near you.
Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private.
Bextra may have higher risk of stroke and heart attack
-October 18, 2004
Pfizer, Inc. announced two small clinical trials showed that heart bypass surgery patients taking its anti-inflammatory drug Bextra had a higher risk of stroke and heart attack. Bextra is a COX-2 inhibitor drug, part of the same class of drug as Merck & Co.'s recently recalled arthritis and pain relief drug Vioxx. Following the Vioxx recall, experts quickly warned that the increased risk of cardiovascular events may be a class - wide effect, bringing closer scrutiny on the two remaining COX-2 inhibitors on the market, Pfizer's Bextra and Celebrex.
Pfizer has also said it is updating Bextra labeling to reflect a stronger warning about a rare but serious skin reaction that can occur mainly in the first two weeks of drug therapy.
For more information on bextra and heart attacks, please contact us.
- Popular Drug Recalls: Avandia
- Yaz Birth Control
- NuvaRing
- Reglan
- Home
- Drug Index
- News Archive
- Resources